FDA identifies deadly heparin contaminant

Officials don't know how compound, which may have killed 19, got into drug

Health care videos

Health care battle
July 2: Dr. Nancy Snyderman discusses the health care battle with former senator Tom Daschle.

Controversy over breast cancer bill

Fight looms over who pays for health reform

'Our current system is unacceptable'

Obama: 'We are at a defining moment'

INTERACTIVE

How would you like health care changed?
As the government ponders health care reform, what are your top concerns?

updated 11:44 a.m. ET March 19, 2008

WASHINGTON - U.S. health regulators have identified the contaminant found in Baxter International's blood thinner heparin, which may be to blame for 19 deaths.

The Food and Drug Administration says a chemical compound called oversulfated chondroitin sulfate has been found in samples of the drug tied to death and allergic reactions.

FDA staff say the chemical comes from a family similar to heparin, but that it is not approved in the U.S. or abroad as a medical treatment.

Story continues below ↓

advertisement | your ad here

FDA drug center director Janet Woodcocks says the agency can't rule whether it was deliberately introduced into the product, but is 99 percent sure it's not a natural component.

Baxter is based in Deerfield, Ill.

Click for related content

FDA warns docs to stop using Baxter's heparin
FDA says contaminant in some Baxter heparin